Skip to Content

Blog

Archives

Akadeum Awarded Top 10 BioTech Startups of 2023 by PharmaTech Outlook

Updated on Sep 8, 2025 | Published on Feb 13, 2024

“Our dedication to thorough research and our commitment to listening to the voice of the customer has resulted in a truly outstanding innovation.” Akadeum Life Sciences was recently featured as a Top 10 BioTech Startup of 2023 by PharmaTech Outlook magazine. In recognition of the award, PharmaTech Outlook published an article highlighting the innovative work happening at Akadeum to reignite the stagnant cell separation market. Akadeum’s microbubble technology overcomes the …

Akadeum CEO Brandon McNaughton Part of Michigan Founders Fund Milestone

Updated on Sep 8, 2025 | Published on Aug 9, 2023

Bio photos of Michigan Founders Fund members

Brandon McNaughton, CEO and co-founder of Akadeum Life Sciences, was recently highlighted with other influential Michigan-based thought leaders in a Purpose Job’s recent article celebrating Michigan Founders Fund’s 100-member milestone. The Michigan Founders Fund (MFF) recently celebrated reaching over 100 members in its statewide venture network supporting high-growth entrepreneurs. MFF members pledge 1% of equity to a fund for grantmaking focused on underrepresented founders, local talent development, and racial equity. …

Akadeum CEO on Sirius XM with Steve Blank

Updated on Sep 8, 2025 | Published on Mar 1, 2016

Akadeum CEO Brandon McNaughton recently sat down for a discussion on Sirius XM with Steve Blank. Steve interviewed Brandon as part of Entrepreneurs are Everywhere, and they discussed topics ranging from cell separation with microbubbles to figuring out how to move an idea from an idea to sales. See select quotes from the interview below. Entrepreneurs are Everywhere “The show follows the journeys of founders who share what it takes …

Akadeum CEO’s Interview With BioWorld: Alerion System to Transform Cell Therapy

Updated on Sep 8, 2025 | Published on Jan 3, 2024

Alerion™ Device Logo

Brandon McNaughton, CEO of Akadeum Life Sciences Inc., recently shared insights with BioWorld about the company’s Alerion™ Microbubble Cell Separation System, set to transform cell therapy. Akadeum, established in 2014, has developed a unique microbubble-based cell separation technology. The Alerion™ Microbubble Cell Separation System promises to overcome the limitations of existing methods, offering better workflows, scalability, and productivity. The Alerion™ system uses a two-chamber consumable, allowing microbubbles to adhere to …

Akadeum Life Sciences Named in Top 10 Most Innovative Biotech Companies of 2023 by Fast Company

Updated on Sep 8, 2025 | Published on Mar 2, 2023

Akadeum Life Sciences Named in Top 10 Most Innovative Biotech Companies of 2023 by Fast Company

The global leader in buoyancy-based cell separation technology recognized for innovation solving workflow challenges in cell and gene therapy research and development ANN ARBOR, Mich., March 02, 2023 — Akadeum Life Sciences Inc., a global leader in buoyancy-based cell separation technology, announces today it has been named in Fast Company’s 10 Most Innovative Biotech Companies of 2023 as part of the prestigious annual list of the World’s Most Innovative Companies. Akadeum’s patented cell …

Akadeum Chosen to Receive Advice from NASA

Updated on Sep 8, 2025 | Published on May 24, 2014

Akadeum Life Sciences is one of several companies in Ohio and Michigan who have been selected to receive advice from NASA. NASA will provide immediate help to five companies at their June 12, 2014 event at the University of Toledo, four companies at the Glenn Center in Cleveland, Ohio, and seven companies on-site or via video-conferencing. Akadeum has been selected to receive on-site or video advice. Read more about this …

Akadeum Life Sciences Previews First-of-its-kind Microbubble Cell Separation Instrument

Updated on Sep 8, 2025 | Published on Oct 11, 2023

This revolutionary instrument marks an important step in bringing the performance advantages of our products into clinical manufacturing workflows.  ANN ARBOR, MI, Oct. 10, 2023 – Akadeum Life Sciences, the global leaders in buoyancy-based cell separation technology, have announced today the preview of their Alerion™cell separation system. The instrument will provide a closed system for separating T cells from a leukopak using Akadeum’s revolutionary Buoyancy Activated Cell Sorting (BACS™) microbubble …

Akadeum Collaboration With Agilent Brings Microbubbles to Wastewater Testing

Updated on Sep 8, 2025 | Published on Mar 8, 2024

Akadeum Life Sciences has joined forces with Agilent to combat the spread of infectious diseases through innovative wastewater testing kits. Highlighted in a recent Patient Safety & Quality Healthcare publication, this collaboration will revolutionize public health surveillance, providing a faster, simpler, and more efficient alternative to traditional methods when extracting important diagnostic markers from wastewater samples. The new Viral DNA-RNA Wastewater Prep Kit leverages microbubbles to extract nucleic acids gently …

Akadeum Life Sciences Receives 2023 Best of Ann Arbor Award

Updated on Sep 8, 2025 | Published on Oct 4, 2023

These exceptional companies help make the Ann Arbor area a great place to live, work and play. ANN ARBOR September 26, 2023 — Akadeum Life Sciences has been selected for the 2023 Best of Ann Arbor Award in the Biotechnology Company category by the Ann Arbor Award Program. Each year, the Ann Arbor Award Program identifies companies that we believe have achieved exceptional marketing success in their local community and …

Akadeum Granted Patent for Buoyancy-Based Cell Separation “Microbubble” Technology

Updated on Sep 8, 2025 | Published on Jun 20, 2022

The patent bolsters Akadeum’s intellectual property and protects its current and future roster of buoyant separation products and applications ANN ARBOR, Mich., June 20, 2022 — Akadeum Life Sciences, Inc., a global leader in buoyancy-based technology in cell therapy manufacturing, clinical diagnostics, and cell and molecular research for human health and life sciences, today announces a patent issuance for its proprietary method of buoyancy-based cell sorting (BACS ™) technologies from biological fluid …

Back to Top